| 201 | CAPITAL SOUTHWEST CORP | 22.464 | 496.904 $ | |
| 202 | First Trust Senior Floating Rate Income Fund II | 51.545 | 496.894 $ | |
| 203 | BlackRock Debt Strategies Fund | 51.502 | 493.904 $ | |
| 204 | Eaton Vance Senior Income Trust | 98.865 | 493.336 $ | |
| 205 | GLADSTONE CAPITAL CORP | 28.409 | 492.896 $ | |
| 206 | EATON VANCE MUNICIPAL INCOME TRUST | 45.894 | 492.443 $ | |
| 207 | Sixth Street Specialty Lending Inc | 26.629 | 489.441 $ | |
| 208 | Ultragenyx Pharmaceutical Inc | 23.302 | 488.177 $ | |
| 209 | MSC Income Fund Inc | 39.921 | 486.238 $ | |
| 210 | Corvus Pharmaceuticals Inc | 32.579 | 476.631 $ | |
| 211 | FS Credit Opportunities Corp | 91.877 | 468.573 $ | |
| 212 | Rezolute Inc | 151.492 | 462.051 $ | |
| 213 | Tyra Biosciences Inc | 12.049 | 461.477 $ | |
| 214 | Barings BDC Inc | 55.991 | 460.806 $ | |
| 215 | CG oncology Inc | 6.660 | 450.749 $ | |
| 216 | SLR Investment Corp | 31.335 | 448.404 $ | |
| 217 | WHITEHORSE FINANCE INC | 60.566 | 448.188 $ | |
| 218 | Oruka Therapeutics Inc | 9.034 | 443.118 $ | |
| 219 | Allogene Therapeutics Inc | 180.588 | 440.635 $ | |
| 220 | Kodiak Sciences Inc | 11.451 | 436.512 $ | |
| 221 | Arcellx Inc | 3.794 | 435.627 $ | |
| 222 | Ares Capital Corp | 23.885 | 430.408 $ | |
| 223 | Nuvation Bio Inc | 100.151 | 429.648 $ | |
| 224 | Tectonic Therapeutic Inc | 13.799 | 426.527 $ | |
| 225 | LENZ Therapeutics Inc | 46.542 | 425.859 $ | |
| 226 | Ares Public Funds | 34.335 | 417.514 $ | |
| 227 | Blackstone Senior Floating Rat | 31.759 | 411.279 $ | |
| 228 | Spyre Therapeutics Inc | 8.110 | 409.068 $ | |
| 229 | CENTESSA PHARMACEUTICALS PLC | 10.286 | 408.560 $ | |
| 230 | Blackrock Income Trust Inc. | 38.229 | 404.081 $ | |
| 231 | Morgan Stanley Direct Lending Fund | 28.292 | 394.956 $ | |
| 232 | Blackstone Strategic Credit 2027 Term Fund | 35.175 | 392.201 $ | |
| 233 | BLACKROCK LTD DURATION INCOME TRUST | 30.934 | 389.459 $ | |
| 234 | Intellia Therapeutics Inc | 30.230 | 387.549 $ | |
| 235 | ADMA Biologics Inc | 42.683 | 384.574 $ | |
| 236 | OXFORD SQUARE CAPITAL CORP | 213.488 | 377.874 $ | |
| 237 | ORIC Pharmaceuticals Inc | 29.069 | 368.304 $ | |
| 238 | Vir Biotechnology Inc | 40.759 | 365.201 $ | |
| 239 | Edgewise Therapeutics Inc | 11.544 | 363.636 $ | |
| 240 | Nuveen Churchill Direct Lending Corp | 28.562 | 363.309 $ | |
| 241 | Nektar Therapeutics | 4.984 | 358.599 $ | |
| 242 | Vaxcyte Inc | 6.126 | 355.982 $ | |
| 243 | Palvella Therapeutics Inc | 2.765 | 344.657 $ | |
| 244 | TRIPLEPOINT VENTURE GROWTH BDC CORP | 68.513 | 341.880 $ | |
| 245 | Relay Therapeutics Inc | 33.957 | 337.872 $ | |
| 246 | AnaptysBio Inc | 6.067 | 336.476 $ | |
| 247 | Revolution Medicines Inc | 3.454 | 335.902 $ | |
| 248 | OFS CAPITAL CORP | 92.665 | 328.961 $ | |
| 249 | Praxis Precision Medicines Inc | 1.013 | 326.378 $ | |
| 250 | Cullinan Therapeutics Inc | 22.875 | 325.054 $ | |
| 251 | Terns Pharmaceuticals Inc | 6.058 | 319.378 $ | |
| 252 | Capricor Therapeutics Inc | 10.479 | 318.562 $ | |
| 253 | Celldex Therapeutics Inc | 9.911 | 314.377 $ | |
| 254 | Liquidia Corp | 8.169 | 308.298 $ | |
| 255 | Belite Bio Inc | 1.929 | 307.560 $ | |
| 256 | CytomX Therapeutics Inc | 65.080 | 305.876 $ | |
| 257 | Immunome Inc | 13.932 | 304.693 $ | |
| 258 | Annexon Inc | 54.866 | 303.958 $ | |
| 259 | Protagonist Therapeutics Inc | 2.860 | 301.444 $ | |
| 260 | Apogee Therapeutics Inc | 3.538 | 297.793 $ | |
| 261 | Celcuity Inc | 2.589 | 295.508 $ | |
| 262 | Summit Therapeutics Inc | 15.519 | 294.240 $ | |
| 263 | Bicara Therapeutics Inc | 14.755 | 293.477 $ | |
| 264 | Denali Therapeutics Inc | 15.166 | 291.187 $ | |
| 265 | Amylyx Pharmaceuticals Inc | 20.815 | 289.329 $ | |
| 266 | Rocket Pharmaceuticals Inc | 80.438 | 287.968 $ | |
| 267 | Precigen Inc | 73.899 | 285.989 $ | |
| 268 | Scholar Rock Holding Corp | 5.816 | 285.915 $ | |
| 269 | Main Street Capital Corp. | 5.380 | 284.925 $ | |
| 270 | Omeros Corp | 26.865 | 283.694 $ | |
| 271 | Cytokinetics Inc | 4.303 | 283.611 $ | |
| 272 | Rapport Therapeutics Inc | 9.007 | 281.829 $ | |
| 273 | Compass Therapeutics Inc | 52.846 | 279.555 $ | |
| 274 | Monte Rosa Therapeutics Inc | 16.718 | 275.011 $ | |
| 275 | Stoke Therapeutics Inc | 8.418 | 274.090 $ | |
| 276 | Arcus Biosciences Inc | 12.664 | 273.542 $ | |
| 277 | MBX Biosciences Inc | 9.131 | 272.560 $ | |
| 278 | Zymeworks Inc | 10.702 | 267.978 $ | |
| 279 | Ironwood Pharmaceuticals Inc | 76.169 | 267.353 $ | |
| 280 | Ideaya Biosciences Inc | 8.014 | 267.026 $ | |
| 281 | Nuvalent Inc | 2.602 | 266.575 $ | |
| 282 | Neurogene Inc | 13.033 | 262.745 $ | |
| 283 | Septerna Inc | 10.719 | 257.578 $ | |
| 284 | ArriVent Biopharma Inc | 11.165 | 257.577 $ | |
| 285 | Dyne Therapeutics Inc | 14.150 | 256.540 $ | |
| 286 | Immunovant Inc | 10.320 | 256.349 $ | |
| 287 | JADE BIOSCIENCES INC | 18.203 | 255.752 $ | |
| 288 | Sionna Therapeutics Inc | 6.374 | 255.534 $ | |
| 289 | Kymera Therapeutics Inc | 3.040 | 253.202 $ | |
| 290 | Cogent Biosciences Inc | 6.476 | 249.261 $ | |
| 291 | Janux Therapeutics Inc | 17.821 | 247.712 $ | |
| 292 | BCP INVESTMENT CORP | 32.830 | 246.882 $ | |
| 293 | Viking Therapeutics Inc | 7.354 | 239.299 $ | |
| 294 | Beam Therapeutics Inc | 9.966 | 237.490 $ | |
| 295 | 4D Molecular Therapeutics Inc | 25.154 | 234.184 $ | |
| 296 | Prime Medicine Inc | 66.508 | 231.448 $ | |
| 297 | Inhibrx Biosciences Inc | 3.425 | 230.263 $ | |
| 298 | Arvinas Inc | 21.676 | 229.766 $ | |
| 299 | AtaiBeckley Inc | 63.563 | 225.013 $ | |
| 300 | Compass Pathways plc | 40.457 | 223.727 $ | |